United States temporarily suspends duties on infant formula
H.R. 8351, the “Formula Act” signed into law
H.R. 8351, the “Formula Act” signed into law
President Biden on July 22, 2022, signed into law H.R. 8351, the “Formula Act”—legislation that temporarily suspends duty on imports of certain infant formula products.
U.S. Customs and Border Protection (CBP) announced that it will provide duty-free treatment of the eligible infant formula products entered or withdrawn from warehouse for consumption from July 22, 2022, through December 31, 2022.
CBP’s Office of Trade has updated the Harmonized Tariff Schedule of the United States (HTSUS) file in the Automated Commercial Environment (ACE) to account for this duty-free treatment. According to a CBP transmittal message:
- Duty-free treatment is limited to certain infant formula products classified under the designated HTSUS numbers.
- The eligible infant formula products will not be subject to any additional safeguard duties that may be imposed under subchapter IV of Chapter 99 of the HTSUS, or any other import quotas, tariff-rate quotas, additional duties, or any other duties, fees, exactions, or charges that otherwise would apply to such articles.
For more information, contact a professional with KPMG’s Trade & Customs services:
Doug Zuvich |
John L. McLoughlin |
Andy Siciliano |
Steve Brotherton |
Luis (Lou) Abad |
Irina Vaysfeld |
Amie Ahanchian |
Christopher Young |
Gisele Belotto |
George Zaharatos |
Andy Doornaert |
Jessica Libby Principal E: jlibby@kpmg.com |
The KPMG name and logo are trademarks used under license by the independent member firms of the KPMG global organization. KPMG International Limited is a private English company limited by guarantee and does not provide services to clients. No member firm has any authority to obligate or bind KPMG International or any other member firm vis-à-vis third parties, nor does KPMG International have any such authority to obligate or bind any member firm. The information contained herein is of a general nature and is not intended to address the circumstances of any particular individual or entity. Although we endeavor to provide accurate and timely information, there can be no guarantee that such information is accurate as of the date it is received or that it will continue to be accurate in the future. No one should act on such information without appropriate professional advice after a thorough examination of the particular situation. For more information, contact KPMG's Federal Tax Legislative and Regulatory Services Group at: + 1 202 533 3712, 1801 K Street NW, Washington, DC 20006.